# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA2047477 | 11, MHI-21 | Activity | 0 | ALA2050409 | Active | Homo sapiens | |||||
2. | ALA2047477 | 11, MHI-21 | Activity | = | 13.9 | % | ALA2050408 | % | Homo sapiens | |||
3. | ALA2047477 | 11, MHI-21 | Activity | = | 23.6 | % | ALA2050407 | % | Homo sapiens | |||
4. | ALA2047477 | 11, MHI-21 | Activity | = | 56.5 | % | ALA2050406 | % | Homo sapiens | |||
5. | ALA2047477 | 11, MHI-21 | Activity | 0 | ALA2050405 | Active | Homo sapiens | |||||
6. | ALA2047477 | 11, MHI-21 | EC50 | = | 0.94 | uM | ALA2050404 | 6.03 | nM | Homo sapiens | ||
7. | ALA2047477 | 11, MHI-21 | Drug uptake | 0 | ALA2050403 | Active | ||||||
8. | ALA2047477 | 11, MHI-21 | Drug uptake | 0 | ALA2050402 | Active | ||||||
9. | ALA2047477 | 11, MHI-21 | Drug uptake | 0 | ALA2050401 | Active | ||||||
10. | ALA2047477 | 11, MHI-21 | Drug uptake | 0 | ALA2050400 | Active | ||||||
11. | ALA2047477 | 11, MHI-21 | Drug uptake | 0 | ALA2050399 | Dose-dependent effect | ||||||
12. | ALA2047477 | 11, MHI-21 | Ratio IC50 | = | 3.1 | ALA2050398 | ||||||
13. | ALA2047477 | 11, MHI-21 | Ratio IC50 | = | 2.2 | ALA2050397 | ||||||
14. | ALA2047477 | 11, MHI-21 | Ratio IC50 | = | 2 | ALA2050396 | ||||||
15. | ALA2047477 | 11, MHI-21 | IC50 | = | 100 | uM | ALA2050395 | 4.00 | nM | Homo sapiens | ||
16. | ALA2047477 | 11, MHI-21 | IC50 | = | 12.6 | uM | ALA2050394 | 4.90 | nM | Homo sapiens | ||
17. | ALA2047477 | 11, MHI-21 | IC50 | = | 9.1 | uM | ALA2050393 | 5.04 | nM | Homo sapiens | ||
18. | ALA2047477 | 11, MHI-21 | IC50 | = | 8.3 | uM | ALA2050392 | 5.08 | nM | Homo sapiens | ||
19. | ALA2047477 | 11, MHI-21 | INH | 0 | ALA2050391 | Active | % | |||||
20. | ALA2047477 | 11, MHI-21 | INH | = | 92 | % | ALA2050390 | % | Homo sapiens |